Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving Palbociclib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer in Argentina: The IRIS Study.
Waller J, Mitra D, Mycock K, Taylor-Stokes G, Milligan G, Zhan L, Iyer S. Waller J, et al. Among authors: mycock k. J Glob Oncol. 2019 May;5:JGO1800239. doi: 10.1200/JGO.18.00239. J Glob Oncol. 2019. PMID: 31050919 Free PMC article.
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.
Schneider S, Blick G, Burke C, Ward D, Benson P, Felizarta F, Green D, Donovan C, Harper G, Merrill D, Metzner AA, Mycock K, Wallis H, Patarroyo J, Brogan AP, Oglesby A. Schneider S, et al. Among authors: mycock k. Infect Dis Ther. 2024 Apr;13(4):891-906. doi: 10.1007/s40121-024-00961-y. Epub 2024 Apr 3. Infect Dis Ther. 2024. PMID: 38570443 Free PMC article.
Real-World Experience with Dolutegravir-Based Two-Drug Regimens.
Ward D, Ramgopal M, Riedel DJ, Garris C, Dhir S, Waller J, Roberts J, Mycock K, Oglesby A, Collins B, Dominguez M, Pike J, Mrus J. Ward D, et al. Among authors: mycock k. AIDS Res Treat. 2020 Jul 7;2020:5923256. doi: 10.1155/2020/5923256. eCollection 2020. AIDS Res Treat. 2020. PMID: 32724674 Free PMC article.
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses.
Benson P, Kuretski J, Donovan C, Harper G, Merrill D, Metzner AA, Mycock K, Wallis H, Brogan AP, Patarroyo J, Oglesby A. Benson P, et al. Among authors: mycock k. Infect Dis Ther. 2024 Apr;13(4):875-889. doi: 10.1007/s40121-024-00950-1. Epub 2024 Apr 3. Infect Dis Ther. 2024. PMID: 38570444 Free PMC article.
13 results